meitshel

GRTS - Potential Gap Play

Long
meitshel Updated   
NASDAQ:GRTS   Gritstone bio, Inc.
Gritstone Bio Inc is a biotechnology company. The company is engaged in developing personalized cancer immunotherapies to fight multiple cancer types and infectious diseases. It is building a pipeline of Immunotherapies product candidates for patients with solid tumors, which includes GRANITE, SLATE, and CORAL, among others.

Disclaimer: This content is for informational purposes only and is not intended as financial advice.

Upcoming Catalyst:

Date: 3Q 2024
Details: Anticipating a potential pre-run-up leading to the data release.

Investment Overview (Dated 03/05/2024):

Relative Volume: 1.51
Shares Float: 97.27 million
Short Float: 13.16%

Key Technical Levels:

Potential Gap Fill: Above $1.00 needs to break for confirmation.

Resistance Levels: Look for resistance at $1.40, $1.80, and $2.05. Breaking above these levels could indicate an upward trend. Taking partial profits at these points might secure gains.

Trading Strategy:

Take Profit (TP): Target a profit at $2.20 to achieve a full gap fill.

Stop Loss (SL): Set a stop loss below $0.80 to minimize potential losses.

Chart Analysis:

Refer to the accompanying chart for a comprehensive analysis of price movements and trend lines.

Trading Caution:

Trade with careful consideration of market conditions and personal risk tolerance.
Conduct thorough research or consult a financial advisor before making investment decisions.
Comment:
Tuesday May 7, 2024
GRTS
Block Trade: GRTS 2.1M @ $1.01
Trade closed: stop reached:
SL hit
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.